1. New cyclic dipeptide discovered from deep-sea derived Aspergillus sp. HDN20-1401.
- Author
-
Anjum K, Huang X, Zhou L, Zhu T, Che Q, Zhang G, and Li D
- Subjects
- Molecular Structure, Antineoplastic Agents pharmacology, Antineoplastic Agents chemistry, Antineoplastic Agents isolation & purification, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents chemistry, Humans, Magnetic Resonance Spectroscopy, Alkaloids chemistry, Alkaloids pharmacology, Alkaloids isolation & purification, Aspergillus chemistry, Microbial Sensitivity Tests, Bacillus cereus drug effects, Dipeptides chemistry, Dipeptides pharmacology, Peptides, Cyclic chemistry, Peptides, Cyclic pharmacology, Peptides, Cyclic isolation & purification
- Abstract
A new alkaloid named aspergilalkaloid A ( 1 ) with pyridoindole hydroxymethyl piperazine dione structure along with six known compounds 2-7 were isolated from deep-sea derived fungus Aspergillus sp. HDN20-1401. The structure including absolute configuration was elucidated by extensive NMR analyses, HRESIMS, ECD calculation, and theoretical NMR calculation with DP4+ analysis. All isolated compounds were tested for antimicrobial and anticancer activity. Aspergilalkaloid A ( 1 ) showed inhibitive activity against Bacillus cereus with MIC value of 12.5 μ M and weak activity against MRCNS.
- Published
- 2024
- Full Text
- View/download PDF